Ascidian Therapeutics
Jason Thresher has worked in the field of science for over 25 years. Jason began their career in 1996 as an Associate Scientist I and Assistant Scientist II at Scriptgen Pharmaceuticals, Inc. In 2002, they were a Research Associate at Wyeth Research (Contracted from Kelly Scientific Resources) and a Scientist, Senior Associate Scientist, and Research Associate at AstraZeneca. Jason then worked as a Scientist and Senior Research Associate at Kaleido Biosciences, Inc. from 2015 until 2022, when they became a Scientist II at Ascidian Therapeutics.
Jason Thresher completed a Bachelor of Science (BS) in Molecular and Cell Biology from the University of Connecticut, followed by a Master of Science (MS) in Microbiology from the University of Massachusetts Amherst.
This person is not in any offices
Ascidian Therapeutics
2 followers
Gene therapy is entering a new era as the field moves forward. But current technologies cannot overcome the challenges of many diseases. Ascidian’s unique approach aims to unlock these doors and enable treatment for millions of patients worldwide.